Pharmacotherapy for exercise-induced asthma: allowing normal levels of activity and sport

References

• Areteus of Cappadocia. The Extant Works of Areteus, the Cappadocium. Francis Adams (Ed.). Sydenham Society, London, UK 316 (1856).
   Google Scholar
• Major RH. A note on the history of asthma. In: Science, Medicine and History (Volume 2). Underwood EA (Ed.). Oxford University Press, London, UK 522 (1953).
   Google Scholar
• Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is…. J. Allergy Clin. Immunol.106(3), 453–459 (2000).
   PubMed Web of Science ®Google Scholar
• Scherr MS, Frankel L. Physical conditioning for asthmatic children. JAMA168(15), 1996–2000 (1958).
   PubMed Web of Science ®Google Scholar
• Fitch KD, Morton AR, Blanksby BA. Effects of swimming training on children with asthma. Arch. Dis. Child.51(3), 190–194 (1976).
   PubMed Web of Science ®Google Scholar
• Fitch KD. β2-agonists at the Olympic Games. Clin. Rev. Allergy Immunol.31(2–3), 259–268 (2006).
   PubMed Web of Science ®Google Scholar
• Langdeau JB, Boulet LP. Prevalence and mechanisms of asthma and airway hyperesponsiveness in athletes. Sports Med.31(8), 601–616 (2001).
   PubMed Web of Science ®Google Scholar
• Strauss RH, McFadden ER, Ingram RH, Deal SF. Influence of heat and humidity on airway obstruction by exercise in asthma. J. Clin. Invest.61(2), 433–440 (1978).
   PubMed Web of Science ®Google Scholar
• Anderson SD, Daviskas E, Schoeffel RE, Unger SF. Prevention of severe exercise-induced asthma with hot humid air. Lancet2(8143), 629 (1979).
   PubMed Web of Science ®Google Scholar
• Anderson SD, Kippelen P. Airway injury as a mechanism for exercise-induced bronchoconstriction in elite athletes J. Allergy Clin. Immunol.122(2), 225–235 (2008).
   PubMed Web of Science ®Google Scholar
• Dahlén SE, Kumlin M. Monitoring mast cell activation by prostaglandin D2in vivo. Thorax59(6), 453–455 (2004).
   PubMed Web of Science ®Google Scholar
• Gulliksson M, Palmberg L, Nilsson G, Ahlstedt S, Kumlin M. Release of prostaglandin D2 and leukotrine C in response to hypermolar stimulation of mast cells. Allergy61(12), 1473–1479 (2006).
   PubMed Web of Science ®Google Scholar
• Lee TH, Brown MJ, Nagy L, Causon R, Walport MJ, Kay AB. Exercise-induced release of histamine and neutrophil chemotactic factor in atopic asthmatics. J. Allergy Clin. Immunol.70(2), 73–81 (1982).
   PubMed Web of Science ®Google Scholar
• Roca J, Whipp BJ, Augusti AGN et al. Clinical exercise testing with reference to lung diseases: indications, standardization, interpretation strategies. Position statement of the European Respiratory Society. Eur. Respir. J.10(11), 2662–2689 (1997).
   PubMed Web of Science ®Google Scholar
• Crapo RO, Casaburi R, Coates AL et al. Guidelines for methacholine and exercise challenge testing – 1999. Official statement of the American Thoracic Society. Am. J. Respir. Crit. Care Med.161(1), 309–329 (2000).
   PubMed Web of Science ®Google Scholar
• Rundell KW, Slee JB. Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes. J. Allergy Clin. Immunol.122(2), 238–246 (2008).
   PubMed Web of Science ®Google Scholar
• Anderson SD, Fitch K, Perry CP et al. Responses to bronchial challenge submitted for approval to use inhaled β2-agonists before an event at the 2002 Winter Olympics. J. Allergy Clin. Immunol.111(1), 45–50 (2003).
   PubMed Web of Science ®Google Scholar
• Bernard A, Carbonelle S, Michel O et al. Lung hyperpermeability and asthma prevalence in schoolchildren; unexpected associations with the attendance at indoor chlorinated swimming pools. Occup.Environ. Med. 60, 385–394 (2003)
   Google Scholar
• Brunekreef B, Hoek G,Breugelmans O, Leentvaar M. Respiratory effects of low-level photochemical air pollution in amateur cyclists. Am. J. Respir. Crit. Care Med.150(4), 962–966 (1994).
   PubMed Web of Science ®Google Scholar
• Kehrl HR, Roger LJ, Hazucha MJ, Horstman DH. Differing response of asthmatics to sulfur dioxide exposure with continuous and intermittent exercise. Am. Rev. Respir. Dis.135(2), 350–355 (1987).
   PubMedGoogle Scholar
• Roger LJ, Horstman DH, McDonnell W et al. Pulmonary function, airway responsiveness and respiratory symptoms in asthmatics following exercise in NO2. Toxicol. Ind. Health6(1), 155–171 (1990).
   PubMed Web of Science ®Google Scholar
• McCreanor J, Cullinan P, Niewenhuijsen MJ et al. Respiratory effects of exposure to diesel traffic in persons with asthma. N. Engl. J. Med.357(23), 2348–2358 (2007).
   PubMed Web of Science ®Google Scholar
• Larsson K, Ohlsén P, Larsson L, Malmberg P, Rydström PO. High prevalence of asthma in cross-country skiers. Br. Med. J.307(6915), 1326–1329 (1993).
   PubMed Web of Science ®Google Scholar
• Karjalainen EM, Laitinen A, Sue-Chu M, Altraja A, Bjermer L, Laitinen LA. Evidence of airway inflammation and remodelling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am. J. Respir. Crit. Care Med.161(6), 2086–2091 (2000).
   PubMed Web of Science ®Google Scholar
• Moore K, Neugebauer R, Lurmann F et al. Ambient ozone concentrations cause increased hospitalizations for asthma in children: an 18-year study in Southern California. Environ. Health Perspect.116(8), 1063–1070 (2008).
   PubMed Web of Science ®Google Scholar
• Rundell KW. Pulmonary function decay in ice hockey players: is there a relationship to ice rink air quality? Inhal. Toxicol.17(3), 117–123 (2004)
   Google Scholar
• Fitch KD, Morton AR. Specificity of exercise in exercise-induced asthma. Br. Med. J.4(5787), 577–581 (1971).
   Google Scholar
• Mustchin CP, Pickering CA. “Coughing water”; bronchial hyperreactivity following swimming in a chlorinated pool. Thorax34(5), 682–683 (1979).
   PubMed Web of Science ®Google Scholar
• Weisel CP, Richardson SD, Nemery B et al. Childhood asthma and environmental exposures at swimming pools; state of the science and research recommendations. Environ. Health Perspect.117(4), 500–507 (2009).
   PubMed Web of Science ®Google Scholar
• Åstrand P-O, Rodahl K. Textbook of work physiology. McGraw Hill Book Company, NY, USA, 389–408 (1970).
   Google Scholar
• Carlsen KH, Engh G, Mørk M. Exercise-induced bronchoconstriction depends on exercise load. Respir. Med.94(4), 750–755 (2000).
   PubMed Web of Science ®Google Scholar
• Henriksen JM, Nielsen TT. Effect of physical training on exercise-induced bronchoconstriction. Acta Paediatr. Scand.72(1), 31–36 (1983).
   PubMed Web of Science ®Google Scholar
• Reiff DB, Choudry NB, Pride NB, Ind PW. The effect of prolonged submaximal warm-up exercise on exercise-induced asthma. Am. Rev. Respir. Dis.139(2), 479–484 (1989).
   PubMed Web of Science ®Google Scholar
• McKenzie DC, McLuckie SL, Stirling DR. The protective effects of continuous and interval exercise in athletes with exercise-induced asthma. Med. Sci. Sports Exerc.26(8), 951–956 (1994).
   PubMed Web of Science ®Google Scholar
• de Bisschop C, Guenard H, Desnot P, Vergeret J. Reduction of exercise-induced asthma in children by short repeated warm ups. Br. J. Sports Med.33(2), 100–104 (1999).
   PubMed Web of Science ®Google Scholar
• Mickleborough TD, Lindley MR, Turner LA. Comparative effects of a high intensity interval warm-up and salbutamol on the bronchoconstrictor response to exercise in asthmatic athletes. Int. J. Sports Med.28(6), 456–462 (2007).
   PubMed Web of Science ®Google Scholar
• Manning PJ, Watson RM, O’Byrne PM. Exercise-induced refractoriness in asthmatic subjects involves leukotriene and prosta-glandin independent mechanisms. Am. Rev. Respir. Dis.148(4 Pt 1), 950–954 (1993).
   PubMedGoogle Scholar
• Nowak D, Jörres R, Magnussen H. Influence of exercise-induced bronchoconstriction on refractoriness. Lung170(2), 75–84 (1992).
   PubMed Web of Science ®Google Scholar
• Brenner AM, Weisner PC, Krogh LA, Loren ML. Effectiveness of a portable face mask in attenuating exercise-induced asthma. JAMA244(19), 2196–2198 (1980).
   PubMed Web of Science ®Google Scholar
• Millqvist E, Bake B, Bengtsson U, Löwhagen O. Prevention of asthma induced by cold air by cellulose-fabric mask. Allergy50(3), 221–224 (1995).
   PubMed Web of Science ®Google Scholar
• Nisar M, Spence DP, West D et al. A mask to modify inspired air temperature and humidity and its effect on exercise induced asthma. Thorax47, 446–450 (1992).
   PubMed Web of Science ®Google Scholar
• Beuther DA, Martin RJ. Efficacy of a heat exchanger mask in cold exercise-induced asthma. Chest129(5), 1188–1193 (2006).
   PubMed Web of Science ®Google Scholar
• Cullum VA, Farmer JB, Jack D, Levy GP. Salbutamol: a new selective β-adrenoceptive receptor stimulant. Br. J. Pharmacol.35(1), 141–151 (1969).
   PubMed Web of Science ®Google Scholar
• Tattersfield AE. Current issues with β-2 adrenoceptor agonists: historical background. Clin. Rev. Allergy Immunol.31(2–3), 107–117 (2006).
   PubMed Web of Science ®Google Scholar
• Anderson SD, Caillaud C, Brannan JD. β-2 agonists and exercise-induced asthma. Clin. Rev. Allergy Immunol.31(2–3), 163–180 (2006).
   PubMed Web of Science ®Google Scholar
• Anderson SD, Seale JP, Rozea P, Bandler L, Theobald G, Lindsay DA. Inhaled and oral salbutamol in exercise-induced asthma. Am Rev. Respir. Dis.114(3), 493–500 (1976).
   PubMed Web of Science ®Google Scholar
• Godfrey S, König P. Inhibition of exercise-induced asthma by different pharmacological pathways. Thorax31(2), 137–142 (1976).
   PubMed Web of Science ®Google Scholar
• Sly RM, Puapan P, Ghazanshahi S, Midha R. Exercise-induced bronchospasm: evaluation of albuterol aerosol. Ann. Allergy34(1), 7–14 (1975).
   PubMedGoogle Scholar
• Hills EA, Davies S, Geary M. Salmefamol and salbutamol in exercise-induced asthma in children. Br. J. Dis. Chest70(2), 78–82 (1976).
   PubMedGoogle Scholar
• Higgs CM, Laszlo G. The duration of protection from exercise-induced asthma by inhaled salbutamol and a comparison with reproterol. Br. J. Dis. Chest77(3), 262–269 (1983).
   PubMedGoogle Scholar
• Bronsky EA, Spector SL, Pearlman DS, Justus SE, Bishop AL. Albuterol aerosol versus albuterol Rotacaps in exercise-induced bronchospasm in children. J. Asthma32(3), 207–214 (1995).
   PubMed Web of Science ®Google Scholar
• Anderson SD, Lambert S, Brannan JD et al. Laboratory protocol for exercise asthma to evaluate salbutamol given by two devices. Med. Sci. Sports Exerc.33(6), 893–900 (2001).
   PubMed Web of Science ®Google Scholar
• Hawkesworth RJ, Sykes AP, Faris M, Mant T, Lee TH. Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction. Ann. Allergy Asthma Immunol.88(5), 473–477 (2002).
   PubMed Web of Science ®Google Scholar
• Brittain RT, Farmer JB, Marshall RJ. Some observations on the β-adrenoceptor agonist properties of the isomers of salbutamol. Br. J. Pharmacol.48(1), 144–147 (1973).
   PubMed Web of Science ®Google Scholar
• Slattery D, Wong SW, Colin AA. Levalbuterol hydrochloride. Pediatr. Pulmonol.33(2), 151–157 (2002).
   PubMed Web of Science ®Google Scholar
• Pearlman DS, Rees W, Schaefer K, Huang H, Andrews WT. An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm. J. Asthma44(9), 729–733 (2007).
   PubMed Web of Science ®Google Scholar
• Morse JL, Jones NL, Anderson GD. The effect of terbutaline in exercise-induced asthma. Am. Rev. Respir. Dis.113(1), 89–92 (1976).
   PubMedGoogle Scholar
• dos Santos JM, Costa H, Ståhl E, Wiren JE. Bricanyl Turbuhaler and Ventolin Rotahaler in exercise-induced asthma. Allergy46(3), 203–205 (1991).
   PubMed Web of Science ®Google Scholar
• Vilsvik J, Schaanning J, Ståhl E, Holthe S. Comparison between Bricanyl Turbuhaler and Ventolin metered dose inhaler in the treatment of exercise-induced asthma. Ann. Allergy67(3), 315–318 (1991).
   PubMedGoogle Scholar
• Svenonius E, Arborelius M, Wiberg R, Ståhl E, Svensson M. A comparison of terbutaline inhaled by Turbuhaler and by a chlorofluorocarbon (CFC) inhaler in children with exercise-induced asthma. Allergy49(6), 408–412 (1994).
   PubMed Web of Science ®Google Scholar
• Rabe KF, Jörres R, Magnussen H. The effect of 10, 50 and 200 micrograms inhaled fenoterol on exercise induced asthma. Clin. Exp. Allergy23(5), 440–445 (1993).
   PubMed Web of Science ®Google Scholar
• Morton AR, Scott CA, Fitch KD. Rimiterol and the prevention of exercise-induced asthma. J. Allergy Clin. Immunol.83(1), 61–65 (1989).
   PubMed Web of Science ®Google Scholar
• Aebischer JC, Benoit RC, Scherrer M. Pirbuterol and salbutamol aerosol for exercise-induced bronchoconstriction. Schweiz Med. Wochenschr.114(46), 1660–1664 (1984).
   PubMedGoogle Scholar
• Morooka T, Nishima S, Ota S. Prevention of exercise-induced bronchospasm in asthmatic children. Effect of aerosol and oral procaterol hydrochloride. J. Asthma24(6), 335–46 (1987).
   PubMed Web of Science ®Google Scholar
• Scheoffel RE, Anderson SD, Seale JP. The protective effect and duration of action of metaproterenol aerosol on exercise-induced asthma. Ann. Allergy46(5), 273–275 (1981).
   PubMedGoogle Scholar
• Anderson SD. Single-dose agents in the prevention of exercise-induced asthma: a descriptive review. Treat. Respir. Med.3(6), 365–379 (2004).
   PubMedGoogle Scholar
• Johnson M. The β-adrenoceptor. Am. J. Respir. Crit. Care Med.158(5 Pt 3), S146–S153 (1998).
   PubMed Web of Science ®Google Scholar
• Ullman A, Svedmyr N. Salmeterol, a new long acting β-2 adrenoceptor agonist; comparison with salbutamol in adult asthmatic patients. Thorax43(9), 674–678 (1988).
   PubMed Web of Science ®Google Scholar
• Anderson SD, Rodwell LT, Du Toit J, Young IH. Duration of protection by inhaled salmeterol in exercise-induced asthma. Chest100(5), 1254–1260 (1991).
   PubMed Web of Science ®Google Scholar
• Newnham DM, Ingram CG, Earnshaw J, Palmer JB, Dhillon DP. Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma. Respir. Med.87(6), 439–444 (1993).
   PubMed Web of Science ®Google Scholar
• Sichletidis L, Daskalopoulou E, Kyriazis G et al. Comparative efficacy of salbutamol and salmeterol in exercise-induced asthma. J. Int. Med. Res.21(2), 81–88 (1993).
   PubMed Web of Science ®Google Scholar
• Schaanning J, Vilsvik J, Henriksen AH, Bratten G. Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction. Ann. Allergy Asthma Immunol.76(1), 57–60 (1996).
   PubMed Web of Science ®Google Scholar
• McAlpine LG, Thomson NC. Prophylaxis of exercise-induced asthma with inhaled formoterol, a long acting β-2 adrenergic agonist. Respir. Med.84(4), 293–295 (1990).
   PubMed Web of Science ®Google Scholar
• Richter K, Jamicki S, Jörres RA, Magnussen H. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline. Eur. Respir. J.19(5), 865–871 (2002).
   PubMed Web of Science ®Google Scholar
• Boner AL, Spexia E, Piovesan P, Chiocca E, Maiocchi G. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children. Am. J. Respir. Crit. Care Med.149(4 Pt 1), 935–939 (1994).
   PubMed Web of Science ®Google Scholar
• Shapiro GS, Yegen U, Xiang J, Kottakis J, Della Cioppa G. A randomized, double blind, single crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol. Clin. Ther.24(12), 2077–2087 (2002).
   PubMed Web of Science ®Google Scholar
• Pearlman D, Milgrom H, Till D, Ziehmer B. Effect of formoterol fumarate treatment on exercise-induced bronchoconstriction in children. Ann. Allergy Asthma Immunol.97(3), 382–388 (2006).
   PubMed Web of Science ®Google Scholar
• Inman MD, O’Byrne PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am. J. Respir. Crit. Care Med.153(1), 65–69 (1996).
   PubMed Web of Science ®Google Scholar
• Hancox RJ, Subbarao P, Kamada D, Watson RM, Hargreave FE, Inman MD. β2-agonist tolerance and exercise-induced bronchospasm. Am.J. Crit Care Med.165(8), 1068–1070 (2002).
   Web of Science ®Google Scholar
• Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP. Reduced protection against exercise-induced bronchoconstriction after chronic dosing with salmeterol. Respir. Med.88(5), 363–368 (1994).
   PubMed Web of Science ®Google Scholar
• Simons FE, Gerstner TV, Cheang MS. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics99(5), 655–659 (1997).
   PubMed Web of Science ®Google Scholar
• Haney S, Hancox RJ. Overcoming β-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled studies. Respir. Res.8(1), 19 (2007).
   PubMedGoogle Scholar
• Fitch KD, Sue-Chu M, Anderson SD et al. Asthma and the elite athlete: Summary of the International Olympic Committee’s Consensus Conference Lausanne Switzerland, January 22–24, 2008. J. Allergy Clin. Immunol.122(2), 254–260 (2008).
   PubMed Web of Science ®Google Scholar
• Weinberger M. Long-acting β-agonists and exercise. J. Allergy Clin. Immunol.122(2), 251–253 (2008).
   PubMed Web of Science ®Google Scholar
• Haney S, Hancox RJ. Tolerance to bronchodilation during treatment with long acting β-agonists, a randomised controlled trial. Respir. Res.6(1), 107 (2005).
   PubMedGoogle Scholar
• Davis BE, Reid JK, Cockcroft DW. Formoterol thrice weekly does not result in the development of tolerance to bronchoprotection. Can. Respir. J.10(1), 23–26 (2003).
   PubMedGoogle Scholar
• Haney S, Hancox RJ. Rapid onset of tolerance to β-agonist bronchodilation. Respir. Med.99(5), 566–571 (2005).
   PubMed Web of Science ®Google Scholar
• Taylor DR. The β-agonist saga and its clinical relevance: on and on it goes. Am. J. Resp. Crit. Care Med.179(11), 976–978 (2009).
   PubMed Web of Science ®Google Scholar
• Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest129(1), 15–26 (2006).
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long acting β-agonists on severe asthma exacerbations and asthma-related deaths. Ann. Intern. Med.144(12), 904–912 (2006).
   PubMed Web of Science ®Google Scholar
• Cates CJ, Cates MJ. Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst. Rev.16(3), CD006363 (2008).
   Google Scholar
• Cates CJ, Cates MJ, Lasserson TJ. Regular treatment regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database Syst. Rev.4, CD006923 (2008).
   Google Scholar
• Wijesinghe M, Perrin K, Harwood M, Weatherall M, Beasley R. The risk of asthma mortality with inhaled long acting β-agonists. Postgrad. Med. J.84(995), 467–472 (2008).
   PubMed Web of Science ®Google Scholar
• Rodrigo GJ, Moral VP, Marcos LG, Castro-Rodrigues JA. Safety of regular use of long acting b agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review. Pulm. Pharmacol. Ther.22(1), 9–19 (2009).
   PubMed Web of Science ®Google Scholar
• Cazzola M, Matera MG. Safety of long acting β-2 agonists in the treatment of asthma. Ther. Adv. Respir. Dis.1(1), 35–46 (2007).
   PubMedGoogle Scholar
• Koh MS, Irving LB. Evidence-based pharmacologic treatment for mild asthma. Int. J. Clin. Pract.61(8), 1375–1379 (2007).
   PubMed Web of Science ®Google Scholar
• Adams NP, Jones PW. The dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of Cochrane systematic reviews. Respir. Med.100(8), 1297–1306 (2006).
   PubMed Web of Science ®Google Scholar
• Cole TJ, Mollard R. Selective glucocorticoid receptor ligands. Med. Chem.3(5), 494–506 (2007).
   PubMed Web of Science ®Google Scholar
• König P, Jaffe P, Godfrey S. Effect of corticosteroids on exercise-induced asthma provoked by treadmill running. J. Allergy Clin. Immunol.54(1), 14–19 (1974).
   PubMed Web of Science ®Google Scholar
• Freezer NJ, Croasdell H, Doull IJM, Holgate ST. Effect of regular inhaled beclomethasone on exercise and methacholine responses in school children with recurrent wheeze. Eur. Resp. J.8(9), 1488–1493 (1995).
   PubMed Web of Science ®Google Scholar
• Seale JP, Harrison LI. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics. Respir. Med.92(Suppl. A) 9–15 (1998).
   PubMedGoogle Scholar
• Petersen R, Agertoft L, Pedersen S Treatment of exercise-induced asthma with beclomethasone dipropionate in children with asthma. Eur. Respir. J.24(6), 932–937 (2004).
   PubMed Web of Science ®Google Scholar
• Hendriksen JM, Dahl R. Effects of inhaled budesonide alone and in combination with low dose terbutaline in children with exercise-induced asthma. Am. Rev. Respir. Dis.128, 993–997 (1983).
   PubMedGoogle Scholar
• Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Effect of inhaled budesonide on bronchial reactivity to histamine, exercise and eucapnic dry air hyperventilation in patients with asthma. Thorax46(11), 811–816 (1991).
   PubMed Web of Science ®Google Scholar
• Jónasson G, Carlsen KH, Hultqvist P. Low-dose budesonide improves exercise-induced bronchospasm in schoolchildren. Pediatr. Allergy Immunol.11(5), 120–125 (2000).
   PubMed Web of Science ®Google Scholar
• Thio BJ, Slingerland GL, Nagelkerke AF, Roord JJ, Dankert-Roelse JE. Effects of single dose fluticasone on exercise-induced asthma in asthmatic children: a pilot study. Pediatr. Pulmonol.32(2), 115–121 (2001).
   PubMed Web of Science ®Google Scholar
• Hofstra WB, Neijens HJ, Duiverman EJ et al. Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma. Pediatr. Pulmonol.29(6), 415–423 (2000).
   PubMed Web of Science ®Google Scholar
• Christie P. Ciclesonide: a novel inhaled corticosteroid for asthma. Drugs Today (Barc.)40(7), 569–576 (2004).
   PubMed Web of Science ®Google Scholar
• Deeks ED, Perry CM. Ciclesonide: a review of its use in the management of asthma. Drugs68(12), 1741–1770 (2008).
   PubMed Web of Science ®Google Scholar
• Manning P, Gibson PG, Lasserson TJ. Ciclesonide versus other inhaled steroids from chronic asthma in children and adults. Cochrane Database Syst Rev.16(2), CD007031 (2008).
   Google Scholar
• Subbarao P, Doung M, Adelroth E et al. Effect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthma. J. Allergy Clin. Immunol.117(5), 1008–1013 (2006).
   PubMed Web of Science ®Google Scholar
• Jónassen G, Carlsen KH, Blomqvist P. Clinical efficacy of low dose budesonide once or twice daily in children with mild asthma not previously treated with steroids. Eur. Respir. J.12(5), 665–671 (1998).
   Google Scholar
• Hartley JP, Charles TJ, Seaton A. Betamethasone valerate and exercise-induced asthma in adults. Br. J. Dis. Chest71(4), 253–258 (1977).
   PubMedGoogle Scholar
• Yazigi R, Sly RM, Frazer M. Effect of triamcinolone acetonide aerosol upon exercise-induced asthma. Ann. Allergy40(5), 322–325 (1978).
   PubMedGoogle Scholar
• Abdullah AK, Khan S. Relative oral corticosteroid-sparing effect of 7 inhaled corticosteroids in chronic asthma: a meta-analysis. Ann. Allergy Asthma Immunol.101(1), 74–81 (2008).
   PubMed Web of Science ®Google Scholar
• Markham A, Faulds D. Montelukast. Drugs56(2), 251–256 (1998).
   PubMed Web of Science ®Google Scholar
• Kemp JP, Dockhorn RJ, Shapiro GG et al. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6–14 year-old children with asthma. J. Pediatr.133(3), 424–428 (1998).
   PubMed Web of Science ®Google Scholar
• Philip G, Villarán C, Pearlman DS, Loevs T, Dass SB, Reiss TF. Protection against exercise-induced bronchocontriction two hours after a single oral dose of montelukast. J. Asthma44(3), 213–217 (2007).
   PubMed Web of Science ®Google Scholar
• Kim JH, Lee SY, Kim HB, Shim JY, Hong TJ, Hong SJ. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction. Pediatr. Pulmonol.39(2), 162–166 (2005).
   PubMed Web of Science ®Google Scholar
• Pajaron-Fernandez M, Garcia-Rubia S, Sanchez-Solis M, Garcia-Marcos L. Montelukast administered in the morning or evening to prevent exercise-induced bronchoconstriction in children. Pediatr. Pulmonol.41(3), 222–227 (2006).
   PubMed Web of Science ®Google Scholar
• Mastalerz L, Gawlewicz A, Nizankowska E, Cmiel A, Szczeklik A. Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin tolerant patients with asthma. Clin. Exp. Allergy32(9), 1360–1365 (2002).
   PubMed Web of Science ®Google Scholar
• Leff JA, Busse WW, Pearlman D et al. Montelukast, a leukotriene receptor antagonist for the treatment of mild asthma and exercise-induced bronchoconstriction. N. Eng. J. Med.339(3), 147–152 (1998).
   PubMed Web of Science ®Google Scholar
• Pearlman DS, van Adelsberg J, Philip G et al. Onset and duration of protection against exercise-induced bronchoconstriction by a single dose of montelukast. Ann. Allergy Asthma Immunol.97(1), 98–104 (2006).
   PubMed Web of Science ®Google Scholar
• Villaran C, O’Neill SJ, Helbling A et al. Montelukast versus salmeterol in asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol study group. J. Allergy Clin. Immunol.104(3 Pt 1), 547–553 (1999).
   PubMed Web of Science ®Google Scholar
• Edelman JM, Turpin JA, Bronsky EA et al. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double blind trial. Exercise study group. Ann. Intern. Med.132(2), 97–104 (2000).
   PubMed Web of Science ®Google Scholar
• Dahlén B, Roquet A, Inman MD et al. Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction. J. Allergy Clin. Immunol.109(5), 789–793 (2002).
   PubMed Web of Science ®Google Scholar
• Coreno A, Skowronski M, Kotaru C, McFadden ER Jr. Comparative effects of long acting β2 agonists, leukotriene receptor antagonists and a 5-lipoxygenase inhibitor on exercise-induced asthma. J. Allergy Clin. Immunol.106(3), 500–506 (2000).
   PubMed Web of Science ®Google Scholar
• Adelroth E, Inman MD, Summers E, Pace D, Modi M, O’Byne PM. Prolonged protection against exercise-induced bronchoconstriction by the leuketriene D-4 receptor antagonist cinalukast. J. Allergy Clin. Immunol.99(2), 210–215 (1997).
   PubMedGoogle Scholar
• Meltzer SS, Hasday JD, Cohn J, Bleecker ER. Inhibition of exercise-induced bronchoconstriction by zileuton: a 5-lipoxygenase inhibitor. Am. J. Respir. Crit. Care Med.153(3), 931–935 (1996).
   PubMed Web of Science ®Google Scholar
• Howell JB, Altounyan RE. A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet2(7515), 539–542 (1967).
   PubMed Web of Science ®Google Scholar
• Morton AR, Fitch KD. Sodium cromoglycate BP in the prevention of exercise-induced asthma. Med. J. Aust.2(5), 158–162 (1974).
   PubMed Web of Science ®Google Scholar
• Dahl R, Henriksen JM. Effect of oral and inhaled sodium cromoglycate in exercise-induced asthma. Allergy35(4), 363–365 (1980).
   PubMed Web of Science ®Google Scholar
• Corkey C, Mindorff C, Levison H, Newth C. Comparison of three different preparations of disodium cromoglycate in the prevention of exercise-induced bronchospasm: a double blind study. Am. Rev. Respir. Dis.125(6), 623–626 (1982).
   PubMedGoogle Scholar
• Boner AL, Niero E, Grigolini C, Valletta EA, Biancotto R, Gaburro D. Inhibition of exercise-induced asthma by three forms of sodium cromoglycate. Eur. J. Respir. Dis.66(1), 21–24 (1985).
   PubMedGoogle Scholar
• Jones DT, Flannery EM, Sears MR. Exercise-induced asthma; comparison of cromoglycate powder and aerosol four hours before exercise. N. Z. Med. J.97(747), 6–8 (1984).
   PubMed Web of Science ®Google Scholar
• Juniper EF, Kline PA, Morris MM, Hargreave FE. Airway constriction by isocapnic hyperventilation of cold, dry air: comparison of magnitude and duration of protection by nedocromil sodium and sodium cromoglycate. Clin. Allergy17(6), 523–528 (1987).
   PubMedGoogle Scholar
• de Benedictis FM, Tuteri G, Pazzelli P, Bertotto A, Bruni L, Vaccaro R. Cromolyn versus nedocromil; duration of action in exercise-induced asthma in children. J. Allergy Clin. Immunol.96(4), 510–514 (1995).
   PubMed Web of Science ®Google Scholar
• Chudry N, Correa F, Silverman M. Nedocromil sodium and exercise-induced asthma. Arch. Dis Child.62(4), 412–414 (1987).
   PubMed Web of Science ®Google Scholar
• Henriksen JM. Effect of nedocromil sodium on exercise-induced bronchoconstriction in children. Allergy43(6), 449–453 (1988).
   PubMed Web of Science ®Google Scholar
• Cavallo A, Cassaniti C, Glogger A, Magrini H. Action of nedocromil sodium in exercise-induced asthma in adolescents. J. Investig. Allergol. Clin. Immunol.5(5), 286–288 (1995).
   PubMed Web of Science ®Google Scholar
• König P, Hordvik NL, Kreutz C. The preventive effect and duration of action of nedocromil sodium and cromolyn sodium on exercise-induce asthma (EIA) in adults. J. Allergy Clin. Immunol.79(1), 64–68 (1987).
   PubMed Web of Science ®Google Scholar
• Oseid S, Mellbye E, Hem E. Effect of nedocromil sodium on exercise-induced bronchoconstriction exacerbated by inhalation of cold air. Scand. J. Med. Sci. Sports5(2), 88–93 (1995).
   PubMedGoogle Scholar
• Todaro A, Faina M. Alippi B, Dal Monte A, Ruggieri F. Nedocromil sodium in the prevention of exercise-induced bronchospasm in athletes with asthma. J. Sports Med. Phys. Fitness33(2), 137–145 (1993).
   PubMed Web of Science ®Google Scholar
• Vilsvik J, Schaanning J. A comparative study of the effect of three doses of nedocromil sodium and placebo given by pressurized aerosol to asthmatics with exercise-induced bronchoconstriction. Ann. Allergy61(5), 367–370 (1988).
   PubMedGoogle Scholar
• Morton AR, Ogle SL, Fitch KD. Effects of nedocromil sodium, cromolyn sodium and a placebo in exercise-induced asthma. Ann. Allergy68(2), 143–148 (1992).
   PubMedGoogle Scholar
• Kelly K, Spooner CH, Rowe BH. Nedocromil sodium vs sodium cromoglycate for preventing exercise-induced bronchoconstriction in asthmatics. Cochrane Database Syst. Rev.(4), CD002731 (2000).
   Google Scholar
• Gosens R, Zaagsma J, Meurs H, Halayko AJ. Muscarinic receptor signalling in the pathophysiology of asthma and COPD. Respir. Res.7(1), 73 (2006).
   PubMed Web of Science ®Google Scholar
• Gross NJ. Anticholinergic agents in asthma and COPD. Eur. J. Pharmacol.533(1–3), 36–39 (2006).
   PubMed Web of Science ®Google Scholar
• Wolkove N, Kreisman H, Frank H, Gent M. The effect of ipratropium on exercise-induced bronchoconstriction. Ann Allergy47(5 Pt 1), 311–315 (1981).
   PubMedGoogle Scholar
• Boner AL, Vallone G, De Stafano G. Effect of inhaled ipratropium bromide on methacholine and exercise provocation in asthmatic children. Pediatr. Pulmonol.6(2), 81–85 (1989).
   PubMed Web of Science ®Google Scholar
• Poppius H, Sovijärvi AR, Tammilehto L. Lack of protective effect of high dose ipratropium on bronchoconstriction following exercise with cold air breathing in patients with mild asthma. Eur. J. Respir. Dis.68(5), 319–325 (1986).
   PubMedGoogle Scholar
• Knöpfli BH, Bar-Or O. Vagal activity and airway response to ipratropium bromide before and after exercise in ambient and cold conditions in healthy cross country runners. Clin. J. Sport Med.9(3), 170–176 (1999).
   PubMed Web of Science ®Google Scholar
• Knöpfli BH, Bar-Or O, Araújo CG. Effect of ipratropium bromide on EIB in children depends on vagal activity. Med. Sci. Sports Exerc.37(3), 354–359 (2005).
   PubMed Web of Science ®Google Scholar
• Park HW, Yang MS, Park CS et al. Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response. Allergy64(5), 778–783 (2009).
   PubMed Web of Science ®Google Scholar
• Banner KH, Page CP. Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma. Eur. Respir J.8(6), 996–1000 (1995).
   PubMed Web of Science ®Google Scholar
• Ellis EF, Koysooko R, Levy G. Pharmacokinetics of theophylline in children with asthma. Pediatrics58(4), 542–547 (1976).
   PubMed Web of Science ®Google Scholar
• Leung P, Kalisher A, Bell TD. Variation in theophylline clearance rate with time in chronic childhood asthma. J. Allergy Clin. Immunol.59(6), 440–444 (1977).
   PubMed Web of Science ®Google Scholar
• Kelly HW, Murphy S. Serum theophylline levels in asthmatic children receiving sustained-release theophylline tablets. Am. J. Hosp. Pharm.36(12), 1698–1701 (1979).
   PubMedGoogle Scholar
• Bierman CW, Shapiro GG, Pierson WE, Cho YW. Exercise induced bronchospasm in asthmatic children as a dose-response model for theophylline. Int. J. Clin. Pharmacol. Biopharm.16(6), 245–248 (1978).
   PubMedGoogle Scholar
• PollockJ, Kiechel F, Cooper D, Weinberger M. Relationship of serum theophylline concentration to inhibition of exercise-induced bronchoconstriction and comparison with cromolyn. Pediatrics60(6), 840–844 (1977).
   PubMed Web of Science ®Google Scholar
• Magnussen H, Reuss G, Jörres R. Methylxanthines inhibit exercise-induced bronchoconstriction at low serum theophylline concentrations and in a dose-dependent fashion. J. Allergy Clin. Immunol.81(3), 531–537 (1988).
   PubMed Web of Science ®Google Scholar
• Ahmed T, Garrigo J, Danta I. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N. Eng. J. Med.329(2), 90–95 (1993).
   PubMed Web of Science ®Google Scholar
• Shimizu T, Mochizuki H, Shigeta M, Morikawa A. Effect of inhaled indomethacin on exercise-induced bronchoconstriction in children with asthma. Am. J. Respir. Crit. Care Med.155(1), 170–173 (1997).
   PubMed Web of Science ®Google Scholar
• Pavord ID, Wisniewski A, Tattersfield AE. Inhaled frusemide and exercise induced asthma: evidence of a role for inhibitory prostanoids. Thorax47(10), 797–800 (1992).
   PubMed Web of Science ®Google Scholar
• Tecklenburg SL, Mickleborough TD, Fly AD, Bai Y, Stager AM. Ascorbic acid supplementation attenuates exercise induced bronchoconstriction in patients with asthma. Respir. Med.101(8), 1770–1778 (2007).
   PubMed Web of Science ®Google Scholar
• Mickleborough TD, Murray RL, Ionescu AA, Lindley MR. Fish oil supplementation reduced the severity of exercise-induced bronchoconstriction in elite athletes. Am. J. Respir. Crit. Care Med.168(10), 1181–1189 (2003).
   PubMed Web of Science ®Google Scholar
• Baumann JM, Rundell KW, Evans TM, Levine AM. Effects of cysteine donor supplementation on exercise-induced bronchoconstriction. Med. Sci. Sports Exerc.37(9), 1468–1473 (2005).
   PubMed Web of Science ®Google Scholar
• Gotshall RW, Mickleborough TD, Cordain L. Dietary salt restriction improves pulmonary function in exercise-induced asthma. Med. Sci. Sports Exerc.32(11), 1815–1819 (2000).
   PubMed Web of Science ®Google Scholar
• Manjra AI, Nel H, Maharai B. Effect of desloratadine on allergic rhinitis and exercise-induced bronchoconstriction: a placebo controlled study. J. Asthma46(2), 156–159 (2009).
   PubMed Web of Science ®Google Scholar
• Crompton GK. Problem with patients have using pressurised aerosol inhalers. Eur. J. Respir. Dis. Suppl.119, 101–104 (1982).
   PubMedGoogle Scholar
• Kamps AW, van Ewijk B, Roorda RJ, Brand PL. Poor inhalation technique, even after inhalation instructions in children with asthma. Pediatr. Pulmonol.29(1), 39–42 (2000).
   PubMed Web of Science ®Google Scholar
• Melani AS, Zanchetta D, Barbato N et al. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann. Allergy Asthma Immunol.93(5), 439–446 (2004).
   PubMed Web of Science ®Google Scholar
• Plaza V, Sanchis J. Medical personnel and patient skill in the use of metered dose inhalers: a multicentre study. CESEA group. Respiration65(3), 195–198 (1998).
   PubMed Web of Science ®Google Scholar
• Lavorini F, Fontana GA. Targeting drugs to the airways: the role of spacer devices. Expert Opin. Drug Deliv.6(1), 91–102 (2009).
   PubMed Web of Science ®Google Scholar
• Piérart F, Wildhaber JH, Vrancken I, Devadason SG, Le Souëf PN. Washing plastic spacers with household detergent reduces electrostatic charge and greatly improves delivery. Eur. Respir. J.13(3), 673–678 (1999).
   PubMed Web of Science ®Google Scholar
• Chew NY, Reddell HK, Bosnic-Anticevich SZ, Chan HK. Effect of mouthpiece washing on aerosol performance of CFC-free Ventolin. J. Asthma41(7), 721–727 (2004).
   PubMed Web of Science ®Google Scholar
• Virchow JC, Crompton GK, Dal Negro R et al. Importance of inhaler devices in the management of airway disease. Respir. Med.102(1), 10–9 (2008).
   PubMed Web of Science ®Google Scholar
• Miller DP, Tom G, Rasoulivan L, Chipps B. Patient-reported outcomes among omalizumab and salmeterol/flutcasone combination therapy. J. Asthma46(2), 179–185 (2009).
   PubMed Web of Science ®Google Scholar
• Bougault V, Turmel J, Levesque B, Boulet LP. The respiratory health of swimmers. Sports Med.39(4), 295–312 (2009)
   PubMed Web of Science ®Google Scholar
• Helenius I, Rytila P, Sarna S et al. Effect of continuing or finishing high-level sports on airways inflammation, bronchial hyperresponsiveness and asthma; a five year follow-up study of 42 highly trained swimmers. J. Allergy Clin. Immmunol.109(6), 962–968 (2002).
   PubMed Web of Science ®Google Scholar
• Anderson SD, Sue-Chu, Perry CP et al. Bronchial challenges in athletes applying to inhale a β2-agonist at the 2004 Summer Olympics. J. Allergy Clin. Immunol.117(4), 767–773 (2006)
   PubMed Web of Science ®Google Scholar
• The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema: ISAAC. Lancet351(9111), 1225–1232 (1998).
   PubMed Web of Science ®Google Scholar
• European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks and use of asthma medication in the European Community Respiratory Health Survey. Eur. Respir. J.9(4), 687–695 (1996).
   PubMed Web of Science ®Google Scholar
• Resnick AD, Deal EC Jr, Ingram RH Jr, McFadden ER Jr. A critical assessment of the mechanism by which hyperoxia attenuates exercise-induced asthma. J. Clin. Invest.64(2), 541–549 (1979).
   PubMed Web of Science ®Google Scholar
• Anderson SD, Schoeffel RE, Follet R, Perry CP, Daviskas E, Kendall M. Sensitivity to heat and water loss at rest and during exercise in asthmatic patients. Eur. J. Respir. Dis.63(5), 459–471 (1982).
   PubMedGoogle Scholar
• Burr ML, Wat D, Evans C et al. Asthma prevalence in 1973, 1988 and 2003. Thorax61(4), 296–299 (2006).
   PubMed Web of Science ®Google Scholar
• Braman SS. The global burden of asthma. Chest130(1 Suppl.), 4S–12S (2006).
   PubMed Web of Science ®Google Scholar
• Becker JM, Rogers J, Rossini G, Mirchandani H, D’Alonzo GE Jr. Asthma deaths during sports: report of a 7-year experience. J. Allergy Clin Immunol.113(2), 264–267 (2004).
   PubMed Web of Science ®Google Scholar
• DiDario AG, Becker JM. Asthma, sports and death. Allergy Asthma Proc.26(5), 341–344 (2005).
   PubMed Web of Science ®Google Scholar
• Lang DM. Asthma deaths and the athlete. Clin. Rev. Allergy Immunol.29(2), 125–129 (2005).
   PubMed Web of Science ®Google Scholar
• Robinson DM, Egglestone DM, Hill PM, Rea HH, Richards GN, Robinson SM. Effects of a physical conditioning program on asthmatic patients. N. Z. Med. J.105(937), 253–256 (1992).
   PubMed Web of Science ®Google Scholar
• Nelson HS, Carr W, Nathan R, Portnoy JM. Update on the safety of long-acting β-agonists with inhaled corticosteroids in the treatment of asthma. Ann. Allergy Asthma Immunol. 102(1), 11–5 (2009).
   Google Scholar
• Humbert M, Andersson TL, Buhl R. Budesonide/formoterol maintenance and reliever therapy in the management of moderate to severe asthma. Allergy63(12), 1567–1580 (2008).
   PubMed Web of Science ®Google Scholar
• Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G. Retrospective claims study of fluticasone propionate/salmeterol fixed combination use as an initial asthma controller therapy in children despite guideline recommendations. Clin. Ther.31(5), 1056–1063 (2009).
   PubMed Web of Science ®Google Scholar
• Friedman H, WilcoxT, Reardon G, Crespi S, Yawn BP. A retrospective study of the use of fluticasone propionate/salmeterol combination as initial asthma controller therapy in a commercially insured population. Clin. Ther.30(10), 1908–1917 (2008).
   PubMed Web of Science ®Google Scholar
• Taylor DR, Jayaram L, Asher MI, Epton MJ. “As required” combination therapy with inhaled corticosteroids and long acting β2 agonists for asthma: current evidence and recommendations. N. Z. Med. J.121(1285), 106–118 (2008).
   PubMedGoogle Scholar
• Papi A, Carmori G, Adcock IM, Barnes PJ. Rescue treatments in asthma. More than as needed bronchodilation. Chest135(6), 1628–1633 (2009).
   PubMed Web of Science ®Google Scholar
• Yang WH, Martinot JB, Pohunek P et al. Tolerability of indacaterol, a novel once daily β2-agonist in patients with asthma: a randomized, placebo-controlled, 28-day safety study. Ann. Allergy Asthma Immunol.99(6), 555–561 (2007).
   PubMed Web of Science ®Google Scholar
• Cazzola M, Matera MG. Novel long acting bronchodilators for COPD and asthma. Br. J. Pharmacol.155(3), 291–299 (2008).
   PubMed Web of Science ®Google Scholar
• Weiss ST, Litonius AA, Lange C et al. Overview of the pharmacogenetics of asthma treatment. Pharmacogenomics6(5), 311–326 (2006).
   Web of Science ®Google Scholar
• Carroll CL, Stoltz P, Schramm CM, Zucker AR. β2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma. Chest135(5), 1186–1192 (2008).
   PubMed Web of Science ®Google Scholar
• Lima JJ, Blake KV, Tantisira KG, Weiss ST. Pharmacogenetics of asthma. Curr. Opin. Pulm. Med.15(1), 57–62 (2009).
   PubMed Web of Science ®Google Scholar
• Hall IP, Sayers I. Pharmacogenetics and asthma: false hope or new dawn? Eur. Respir. J.29(6), 1239–1245 (2007).
   PubMed Web of Science ®Google Scholar